Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio
WOODCLIFF LAKE, N.J., Jan. 18, 2024 -- Eagle Pharmaceuticals, Inc. today provided an update on its bendamustine intellectual property portfolio. On January 16, 2024, the United States Court...